Common Stock, Shares, Outstanding of Monopar Therapeutics from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Monopar Therapeutics quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2016 to 30 Sep 2025.
  • Monopar Therapeutics Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 6,662,930, a 89% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Monopar Therapeutics Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 6,662,930 +3,137,851 +89% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 6,127,457 -11,474,370 -65% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 6,115,214 -11,368,961 -65% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 6,102,560 +3,121,660 +105% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 3,525,079 -10,673,359 -75% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 17,601,827 +3,703,746 +27% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 17,484,175 +4,262,119 +32% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 2,980,900 -9,965,673 -77% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 14,198,438 +1,342,703 +10% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 13,898,081 +1,197,344 +9.4% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 13,222,056 +601,464 +4.8% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 12,946,573 +348,448 +2.8% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 12,855,735 +265,123 +2.1% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 12,700,737 +118,009 +0.94% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 12,620,592 +50,659 +0.4% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 12,598,125 +1,144,660 +10% 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q3 2021 12,590,612 +1,138,435 +9.9% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 12,582,728 +1,846,755 +17% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 12,569,933 +1,947,110 +18% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 11,453,465 +865,833 +8.2% 31 Dec 2020 10-K 24 Mar 2022 2021 FY
Q3 2020 11,452,177 +2,160,756 +23% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 10,735,973 +1,444,552 +16% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 10,622,823 +1,331,402 +14% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 10,587,632 +1,296,211 +14% 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q3 2019 9,291,421 0 0% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 9,291,421 0 0% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 9,291,421 0 0% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 9,291,421 0 0% 31 Dec 2018 10-K 27 Mar 2020 2019 FY
Q3 2018 9,291,421 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 9,291,421 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 9,291,421 31 Mar 2018 10-Q 11 May 2018 2018 Q1
Q4 2017 9,291,421 +9,291,421 31 Dec 2017 10-K 26 Feb 2019 2018 FY
Q4 2016 0 31 Dec 2016 10-K 26 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.